Displaying drugs 801 - 825 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Temsirolimus | 1030.2871 C56H87NO16 |  | A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR. | Mammalian target of rapamycin (mTOR) kinase inhibitors / Protein Kinase Inhibitors |
| Vinflunine | 816.944 C45H54F2N4O8 |  | A vinca alkaloid used to treat advanced or metastatic transitional cell carcinoma of the urothelial tract after a platinum containing treatment has failed. | Vinca Alkaloids |
| Caspofungin | 1093.331 C52H88N10O15 |  | An echinocandin used to treat a variety of fungal infections. | Antifungal Agents / Echinocandin Antifungal / Echinocandins / Enzyme Inhibitors / Lipopeptides |
| Pafolacianine | 1326.49 C61H67N9O17S4 |  | An optical imaging agent indicated in adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. | Molecular Probes / Optical Imaging Agent |
| Fezolinetant | 358.4 C16H15FN6OS |  | A non-hormonal drug used to treat moderate to severe vasomotor symptoms due to menopause. | Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 Substrates / Genito Urinary System and Sex Hormones / Heterocyclic Compounds, Fused-Ring / Neurokinin 3 Receptor Antagonist / Sulfur Compounds / Thiazoles |
| Gestrinone | 308.4141 C21H24O2 |  | Endometriosis with or without accompanying sterility. Treatment is limited to a single course of 6 months duration per lifetime [L1699, L1700]. | Antigonadotropins and Similar Agents |
| Zuranolone | 409.574 C25H35N3O2 |  | A neuroactive steroid drug used to treat postpartum depression | Central Nervous System Agents / Psychotropic Drugs |
| Ezetimibe | 409.4252 C24H21F2NO3 |  | A cholesterol absorption inhibitor used to lower total cholesterol, LDL-C, Apo-B, and non-HDL-C in primary hyperlipidemia and familial cholesterolemia. | Anticholesteremic Agents / Dietary Cholesterol Absorption Inhibitor / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Teriflunomide | 270.2073 C12H9F3N2O2 |  | A pyrimidine synthesis inhibitor with anti-inflammatory and immunomodulatory properties used to treat patients with the relapsing-remitting form of multiple sclerosis. | Dihydroorotate dehydrogenase (DHODH) inhibitors / Selective Immunosuppressants |
| Vilazodone | 441.5249 C26H27N5O2 |  | An antidepressant agent used for the treatment of major depressive disorder that targets the 5-HT transporter and 5-HT1A receptors. | Agents that produce hypertension |
| Cangrelor | 776.35 C17H25Cl2F3N5O12P3S2 |  | A P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST). | Platelet Aggregation Inhibitors Excl. Heparin |
| Manganese cation | 54.938 Mn |  | A transition metal used for supplementation of manganese during Total Parenteral Nutrition (TPN). | Metals, Heavy / Paramagnetic Contrast Agent / Trace Elements / Transition Elements |
| Mavacamten | 273.336 C15H19N3O2 |  | A myosin inhibitor used to treat obstructive hypertrophic cardiomyopathy. | Amines / Benzene Derivatives / Benzyl Compounds / Cardiac Myosin Inhibitor / Cardiac Therapy / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Pyrimidines / Pyrimidinones |
| Iptacopan | 422.525 C25H30N2O4 |  | A factor B inhibitor used to treat paroxysmal nocturnal hemoglobinuria. | Complement Inactivating Agents |
| Efinaconazole | 348.398 C18H22F2N4O |  | An antifungal agent used to treat onychomycosis, a fungal infection of the nail. | Imidazole and Triazole Derivatives |
| Dutasteride | 528.5297 C27H30F6N2O2 |  | An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase. | Adrenergic alpha-Antagonists |
| Panthenol | 205.254 C9H19NO4 |  | An ingredient used in skin, hair care, and nutritional products but is not an approved medication. | Vitamin B Complex |
| Demecarium | 556.7797 C32H52N4O4 |  | For the topical treatment of chronic open-angle glaucoma. | Cholinesterase Inhibitors / Parasympathomimetics |
| Bendamustine | 358.263 C16H21Cl2N3O2 |  | An antineoplastic nitrogen mustard agent used in the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed following rituximab therapy. | Nitrogen Mustard Analogues |
| Linezolid | 337.3461 C16H20FN3O4 |  | An oxazolidinone antibiotic used to treat infections by susceptible strains of aerobic Gram-positive bacteria. | Agents that produce hypertension / Agents that reduce seizure threshold |
| Naltrexone | 341.4009 C20H23NO4 |  | A narcotic antagonist used in opioid overdose. | Centrally Acting Antiobesity Products / Drugs Used in Alcohol Dependence / Natural Opium Alkaloids |
| Technetium Tc-99m nofetumomab merpentan | Not Available |  | Tc-99m nm is one of the technetium-labeled antibodies and it is indicated for the detection of small-cell lung cancer. The small cell lung cancer is a syndrome characterized by the... | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Blood Proteins / Globulins / Immunoglobulins / Immunoproteins / Organometallic Compounds / Proteins / Serum Globulins |
| Metaxalone | 221.2524 C12H15NO3 |  | A muscle relaxant used to treat muscle pain or spasm. | Central Nervous System Depressants / Centrally-mediated Muscle Relaxation / Drugs that are Mainly Renally Excreted / Muscle Relaxants / Muscle Relaxants, Centrally Acting Agents / Oxazoles / Peripheral Nervous System Agents / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Anidulafungin | 1140.2369 C58H73N7O17 |  | An antifungal used in the treatment of several types of candida infections. | Antifungal Agents / Echinocandin Antifungal / Echinocandins |
| Magnesium acetate tetrahydrate | 214.453 C4H14MgO8 |  | An ionic compound used for electrolyte replenishment and total parenteral nutrition (TPN) therapy. | Laxatives |
Displaying drugs 801 - 825 of 2785 in total